FindTrial
Sign In

Clinical Value of Elastic Imaging Combined with Serological Indicators in diagnosing Liver Fibrosis of Patients with Chronic Hepatitis B

Clinical Value of Elastic Imaging Combined with Serological Indicators in diagnosing Liver Fibrosis of Patients with Chronic Hepatitis B

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800016663
Enrollment
Unknown
Registered
2018-06-14
Start date
2018-08-01
Completion date
Unknown
Last updated
2018-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Hepatitis B Hepatic Fibrosis

Interventions

Gold Standard:Liver biopsy
Index test:ultrasound&#32
elastography&#32
and&#32
serological&#32
detection&#32
before&#32
the&#32
biopsy

Sponsors

Fudan University Affiliated Shanghai Fifth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criteria: (1) patients who underwent liver biopsy; (2) patients who received ultrasound elastography and serological detection before the biopsy.

Exclusion criteria

Exclusion criteria: Exclusion criteria: (1) patients combined with other types of liver disease; (2) patients with severe heart, liver and kidney insufficiency, coma, or puncture site infection; (3) patients associated with liver cancer, immune system disease, or active bleeding and other diseases.

Design outcomes

Primary

MeasureTime frame
SWV;ALT;AST;PLT;TBIL;HA;LN;CIV;PIII NP;—

Countries

China

Contacts

Public ContactXu Bin

Fudan University Affiliated Shanghai Fifth People's Hospital

13801853334@sohu.com+86 18017856419

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026